Free Trial

SBC Medical Group (SBC) Competitors

SBC Medical Group logo
$4.49 +0.02 (+0.45%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SBC vs. PGNY, GRAL, NHC, TDOC, AHCO, VRDN, CDNA, PNTG, AVAH, and AGL

Should you be buying SBC Medical Group stock or one of its competitors? The main competitors of SBC Medical Group include Progyny (PGNY), GRAIL (GRAL), National HealthCare (NHC), Teladoc Health (TDOC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), CareDx (CDNA), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), and Agilon Health (AGL). These companies are all part of the "healthcare" industry.

SBC Medical Group vs. Its Competitors

Progyny (NASDAQ:PGNY) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

94.9% of Progyny shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Comparatively, 89.5% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Progyny had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 3 mentions for Progyny and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.32 beat Progyny's score of 0.10 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Progyny
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SBC Medical Group
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Progyny has higher revenue and earnings than SBC Medical Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Progyny$1.17B1.58$54.34M$0.5737.63
SBC Medical Group$205.42M2.26$46.61MN/AN/A

Progyny currently has a consensus price target of $23.45, indicating a potential upside of 9.35%. Given Progyny's stronger consensus rating and higher probable upside, equities research analysts clearly believe Progyny is more favorable than SBC Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.42
SBC Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Progyny has a net margin of 4.33% compared to SBC Medical Group's net margin of 0.00%. SBC Medical Group's return on equity of 26.72% beat Progyny's return on equity.

Company Net Margins Return on Equity Return on Assets
Progyny4.33% 10.90% 7.20%
SBC Medical Group N/A 26.72%19.60%

Progyny has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500.

Summary

Progyny beats SBC Medical Group on 9 of the 14 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBC vs. The Competition

MetricSBC Medical GroupMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$465.21M$7.31B$5.53B$9.02B
Dividend YieldN/A2.78%5.22%3.99%
P/E RatioN/A27.9427.7920.25
Price / Sales2.2632.39430.22119.26
Price / Cash7.3720.3926.2128.59
Price / Book2.366.698.035.65
Net Income$46.61M$233.06M$3.18B$249.15M
7 Day Performance-3.23%2.51%2.88%2.91%
1 Month Performance-4.87%1.79%1.67%4.11%
1 Year PerformanceN/A37.40%34.26%20.98%

SBC Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBC
SBC Medical Group
N/A$4.49
+0.4%
N/AN/A$465.21M$205.42M0.00N/A
PGNY
Progyny
1.0275 of 5 stars
$22.00
+0.4%
$23.45
+6.6%
-24.6%$1.88B$1.21B38.60310
GRAL
GRAIL
0.6498 of 5 stars
$51.42
+6.3%
$31.50
-38.7%
N/A$1.74B$125.60M-0.841,360Positive News
NHC
National HealthCare
N/A$107.01
-1.0%
N/A-5.1%$1.65B$1.37B13.4112,400
TDOC
Teladoc Health
3.195 of 5 stars
$8.73
+3.8%
$9.60
+9.9%
-10.6%$1.48B$2.57B-1.475,500
AHCO
AdaptHealth
4.0443 of 5 stars
$9.43
-1.3%
$13.40
+42.1%
-5.8%$1.29B$3.25B16.5410,500
VRDN
Viridian Therapeutics
1.7702 of 5 stars
$13.98
-2.4%
$37.56
+168.6%
+26.5%$1.17B$300K-3.6350News Coverage
CDNA
CareDx
4.4398 of 5 stars
$19.54
+1.6%
$30.33
+55.2%
+23.6%$1.07B$333.79M16.99740Positive News
PNTG
The Pennant Group
3.688 of 5 stars
$29.85
+0.2%
$34.60
+15.9%
+10.7%$1.03B$695.24M39.287,000Positive News
High Trading Volume
AVAH
Aveanna Healthcare
1.1239 of 5 stars
$5.23
+4.2%
$5.13
-2.0%
+83.5%$979.37M$2.02B261.5033,500High Trading Volume
AGL
Agilon Health
2.2674 of 5 stars
$2.31
flat
$4.79
+107.2%
-59.8%$956.23M$6.06B-3.921,076

Related Companies and Tools


This page (NASDAQ:SBC) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners